Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 47 Records) |
| Query Trace: Myocardial Infarction and PON1[original query] |
|---|
| The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population. Clinical biochemistry 2010 Dec 43 (18): 1461-3. Kallel Amani, Sediri Yousra, Sbaï Mohamed Hédi, Mourali Mohamed Sami, Feki Moncef, Elasmi Monia, Taieb Samah Haj, Sanhaji Haïfa, Souheil Omar, Mechmeche Rachid, Jemaa Riadh, Kaabachi Nazi |
| Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clinical pharmacology and therapeutics 2011 Oct 90 (4): 561-7. Simon T, Steg P G, Becquemont L, Verstuyft C, Kotti S, Schiele F, Ferrari E, Drouet E, Grollier G, Danchin |
| Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement. Circulation. Cardiovascular genetics 2011 Aug 4 (4): 429-36. Trenk Dietmar, Hochholzer Willibald, Fromm Martin F, Zolk Oliver, Valina Christian M, Stratz Christian, Neumann Franz-Jos |
| Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease. Molecular and cellular biochemistry 2011 Sep 355 (1-2): 289-97. Masud Rizwan, Qureshi Irfan Z |
| First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide data. Cell biochemistry and function 2011 Mar 29 (2): 156-63. Fujihara Junko, Yasuda Toshihiro, Kawai Yasuyuki, Morikawa Norihiro, Arakawa Kenichiro, Koda Yoshiro, Soejima Mikiko, Kimura-Kataoka Kaori, Takeshita Har |
| Cross-sectional study of risk factors for atherosclerosis in the Azorean population. Annals of human biology 2011 May 38 (3): 354-9. Cymbron Teresa, Raposo Mafalda, Kazachkova Nadiya, Bettencourt Conceição, Silva Francisca, Santos Cristina, Dahmani Yahya, Lourenço Paula, Ferin Rita, Pavão Maria Leonor, Lima Manue |
| Predicting clopidogrel response using DNA samples linked to an electronic health record. Clinical pharmacology and therapeutics 2011 Dec . Delaney JT, Ramirez AH, Bowton E, Pulley JM, Basford MA, Schildcrout JS, Shi Y, Zink R, Oetjens M, Xu H, Cleator JH, Jahangir E, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC |
| CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients. Circulation. Cardiovascular interventions 2011 Oct 4 (5): 422-8. Hulot Jean-Sébastien, Collet Jean-Philippe, Cayla Guillaume, Silvain Johanne, Allanic Frédérick, Bellemain-Appaix Anne, Scott Stuart A, Montalescot Gill |
| Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. International journal of cardiology 2013 Sep 167 (6): 2882-8. Verschuren Jeffrey J W, Boden Helèn, Wessels Judith A M, van der Hoeven Bas L, Trompet Stella, Heijmans Bastiaan T, Putter Hein, Guchelaar Henk-Jan, Schalij Martin J, Jukema J Wout |
| Paraoxonase-1 55 LL Genotype Is Associated with No ST-Elevation Myocardial Infarction and with High Levels of Myoglobin. Journal of lipids 2012 2012 601796. Marchegiani Francesca, Spazzafumo Liana, Cardelli Maurizio, Provinciali Mauro, Lescai Francesco, Franceschi Claudio, Antonicelli Rober |
| Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. Pharmacogenetics and genomics 2012 May 22 (5): 355-66. Lynch Amy I, Eckfeldt John H, Davis Barry R, Ford Charles E, Boerwinkle Eric, Leiendecker-Foster Catherine, Arnett Donna |
| Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis. Molecular and cellular biochemistry 2013 Feb 374 (1-2): 233-8. Cozzi L, Campolo J, Parolini M, De Maria R, Patrosso M C, Marocchi A, Parodi O, Penco |
| Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention. European journal of clinical pharmacology 2012 Nov . Tang XF, Wang J, Zhang JH, Meng XM, Xu B, Qiao SB, Wu YJ, Chen J, Wu Y, Chen JL, Gao RL, Yuan JQ, Yang YJ |
| [Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel]. Medicina clínica 2014 Jul 143 (1): 6-12. Cano Pedro, Consuegra-Sánchez Luciano, Conesa Pablo, Torres-Moreno Daniel, Jaulent Leticia, Dau Derek, Picó Francisco, Villegas Manu |
| A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis. Atherosclerosis 2013 Feb . Liu ME, Liao YC, Lin RT, Wang YS, Hsi E, Lin HF, Chen KC, Juo SH |
| Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI. PloS one 2013 8 (2): e52779. Park Kyung Woo, Park Jin Joo, Kang Jeehoon, Jeon Ki-Hyun, Kang Si-Hyuck, Han Jung-Kyu, Lee Sang Eun, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-S |
| [Clopidogrel metabolism related gene polymorphisms in Chinese patients with acute coronary syndrome]. Zhonghua xin xue guan bing za zhi 2012 Nov 40 (11): 11. Feng GX, Liang Y, Bai Y, Chen T, Liu X, Yang YM, Wang XY, Yang YJ, Zhu J |
| Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting. PloS one 2016 11 (2): e0148891. Li Xiao-Qing, Ma Ning, Li Xin-Gang, Wang Bo, Sun Shu-Sen, Gao Feng, Mo Da-Peng, Song Li-Gang, Sun Xuan, Liu Lian, Zhao Xing-Quan, Wang Yi-Long, Wang Yong-Jun, Zhao Zhi-Gang, Miao Zhong-Ro |
| Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies. Medicine 2016 Nov 95 (44): e5298. Hernández-Díaz Yazmín, Tovilla-Zárate Carlos Alfonso, Juárez-Rojop Isela Esther, González-Castro Thelma Beatriz, Rodríguez-Pérez Candelario, López-Narváez María Lilia, Rodríguez-Pérez José Manuel, Cámara-Álvarez José Francis |
| Evaluation of On-Clopidogrel platelet reactivity overtime, SYNTAX SCORE, genetic polymorphisms and their relationship to one year clinical outcomes in STEMI patients undergoing PCI. Minerva cardioangiologica 2017 7 66 (1): 16-25. Erathi Harsha V, Durgaprasad Rajasekhar, Velam Vanjakshamma, Pvgk Sarma, Rodda Madhavi, C Kapil, Kanavath Sreedhar |
| Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2018 Feb . Yeo Khung-Keong, Armstrong Ehrin J, López Javier E, Chen Debbie C, Westin Gregory G, Li Chin-Shang, Anderson David, Hua Amy, Singapuri Anil, Amsterdam Ezra A, Chiamvimonvat Nipavan, Laird John |
| Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. Pharmacogenomics 2018 12 20 (2): 75-83. Melin Kyle, Moon Jee-Young, Qi Qibin, Hernandez-Suarez Dagmar F, Duconge Jorge, Hua Simin, Gonzalez Sara, Zeng Donglin, Kaplan Robert |
| Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study. Scientific reports 2018 1 8 (1): 1229. Joo Hyung Joon, Ahn Sung Gyun, Park Jae Hyoung, Park Ji Young, Hong Soon Jun, Kim Seok-Yeon, Choi WoongGil, Gwon HyeonCheol, Lim Young-Hyo, Kim Weon, Kang Woong Chol, Cho Yun-Hyeong, Kim Yong Hoon, Yoon JungHan, Shin WonYong, Hong Myeong-Ki, Garg Scot, Jang Yangsoo, Lim Do-S |
| Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort. Journal of aging research 2020 4 2020 7417242. Franey Ericha G, Kritz-Silverstein Donna, Richard Erin L, Alcaraz John E, Nievergelt Caroline M, Shaffer Richard A, Bhatnagar Vib |
| Discovering Genotype Variants in an Infant with VACTERL through Clinical Exome Sequencing: A Support for Personalized Risk Assessment and Disease Prevention. Pediatric reports 2021 1 13 (1): 45-56. Pelizzo Gloria, Chiricosta Luigi, Mazzon Emanuela, Zuccotti Gian Vincenzo, Avanzini Maria Antonietta, Croce Stefania, Lima Mario, Bramanti Placido, Calcaterra Valer |
| Novel lipid biomarkers and associated gene polymorphism in young ST-segment elevation myocardial infarction. Indian heart journal 2022 12 75 (1): 68-72. Muheeb Ghazi, Gupta Mohit Dayal, Kunal Shekhar, Basia Deepak, Mp Girish, Bansal Ankit, Yusuf Jamal, Mukhopadhyay Saibal, Tyagi Sanjay, Singh Ri |
| Role of Single Nucleotide Polymorphism L55M in the Paraoxonase 1 Gene as a Risk and Prognostic Factor in Acute Coronary Syndrome. Current issues in molecular biology 2022 12 44 (12): 5915-5932. Doneva-Basheva Krastina I, Gospodinov Konstantin, Tacheva Tanya, Dimov Dimo, Vlaykova Tatyana |
| The risk stratification of coronary vascular disease as linked to homocysteine, its modulating genes, genetic polymorphisms, conventional predictors, and with antihypertensive medicaments. The Chinese journal of physiology 2022 1 64 (6): 298-305. Masud Rizwan, Anjum Aiman Farogh, Anwar Muhammad Zeeshan, Khan Wajahat Ullah, Shahzad Muhammad Akram, Jawwad Ghaza |
| Association of paraoxonase-1 (Q192R) gene polymorphism with coronary artery spasm during cardiac catheterisation in Egyptians. Archives of physiology and biochemistry 2024 8 1-7. Tarek A Abdelaziz, Noha M Mesbah, Dina M Abo-Elmatty, Farah O El-Sabba |
| Polymorphic variants of the genes for enzymes of the antioxidant system, apoptosis and inflammation as potential predictors of myocardial infarction. Vavilovskii zhurnal genetiki i selektsii 2024 12 28 (7): 792-800. T R Nasibullin, V V Erdman, Y R Timasheva, I A Tuktarova, A A Petinseva, G F Koryti |
- Page last reviewed:Feb 1, 2024
- Content source: